Fluid Drained
Surgery Friday

Ovarian Cancer Breakthrough?


Ok, I am skeptical of any reports about "breakthroughs" in treatment of ovarian cancer, but there is a report from the New England Journal of Medicine about  intraperitoneal (IP) chemotherapy delivered through the abdomen as a better form of treatment than traditional intravenous (IV) approaches.  The benefit is a longer median survival time by an average of 16 months.  So while this is not a cure by any means, it can significantly extend the lives of ovarian cancer patients.


The comments to this entry are closed.